Literature DB >> 7533856

Longitudinal assessment of feline immunodeficiency virus kinetics in plasma by use of a quantitative competitive reverse transcriptase PCR.

L J Diehl1, C K Mathiason-DuBard, L L O'Neil, E A Hoover.   

Abstract

Cats infected with feline immunodeficiency virus (FIV) develop a disease syndrome similar to that caused by human immunodeficiency virus type 1 (HIV-1) infection in humans. HIV-1 replication has been shown to correlate with the disease stage and progression. To assess replication kinetics and disease progression in early FIV infection, we developed a quantitative competitive reverse transcriptase PCR to measure the plasma virus load at serial time points after virus exposure. We found that an early peak viremia immediately preceded the onset of acute-phase symptoms in infected cats. Plasma virus levels remained high throughout the symptomatic phase of infection, which lasted for 8 to 10 weeks, and then declined as clinical symptoms resolved; however, all cats maintained significant plasma virus titers through 36 weeks postinfection. Early peak viral replication coincided with the initial precipitous decline in circulating CD4+ T lymphocytes. These results indicate that FIV kinetics are similar to those of HIV-1 during the acute and secondary phase of infection and that the plasma FIV load correlates with the disease stage. These results serve to further develop the FIV model and to enhance its usefulness for pathogenesis, vaccine development, and therapeutic studies related to HIV.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7533856      PMCID: PMC188904     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Characterization of T-cell subsets and T-cell receptor subgroups in pigtailed macaques using two- and three-color flow cytometry.

Authors:  I Axberg; M J Gale; B Afar; E A Clark
Journal:  J Clin Immunol       Date:  1991-07       Impact factor: 8.317

2.  Flow cytometric analysis of T-lymphocyte subsets in cats.

Authors:  G A Dean; S L Quackenbush; C D Ackley; M D Cooper; E A Hoover
Journal:  Vet Immunol Immunopathol       Date:  1991-07       Impact factor: 2.046

3.  Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species.

Authors:  M Piatak; K C Luk; B Williams; J D Lifson
Journal:  Biotechniques       Date:  1993-01       Impact factor: 1.993

4.  Plasma HIV-1 viremia in HIV-1 infected individuals assessed by polymerase chain reaction.

Authors:  S Aoki-Sei; R Yarchoan; S Kageyama; D T Hoekzema; J M Pluda; K M Wyvill; S Broder; H Mitsuya
Journal:  AIDS Res Hum Retroviruses       Date:  1992-07       Impact factor: 2.205

5.  Feline immunodeficiency virus: quantification in peripheral blood mononuclear cells and isolation from plasma of infected cats.

Authors:  J Meers; W F Robinson; G M del Fierro; M A Scoones; M A Lawson
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

6.  High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.

Authors:  M Piatak; M S Saag; L C Yang; S J Clark; J C Kappes; K C Luk; B H Hahn; G M Shaw; J D Lifson
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

7.  High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.

Authors:  S J Clark; M S Saag; W D Decker; S Campbell-Hill; J L Roberson; P J Veldkamp; J C Kappes; B H Hahn; G M Shaw
Journal:  N Engl J Med       Date:  1991-04-04       Impact factor: 91.245

8.  Detection of feline immunodeficiency virus in saliva and plasma by cultivation and polymerase chain reaction.

Authors:  D Matteucci; F Baldinotti; P Mazzetti; M Pistello; P Bandecchi; R Ghilarducci; A Poli; F Tozzini; M Bendinelli
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

9.  Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion.

Authors:  D A Cooper; J Gold; P Maclean; B Donovan; R Finlayson; T G Barnes; H M Michelmore; P Brooke; R Penny
Journal:  Lancet       Date:  1985-03-09       Impact factor: 79.321

10.  Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome.

Authors:  N C Pedersen; E W Ho; M L Brown; J K Yamamoto
Journal:  Science       Date:  1987-02-13       Impact factor: 47.728

View more
  28 in total

1.  Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats.

Authors:  J S Yang; R V English; J W Ritchey; M G Davidson; T Wasmoen; J K Levy; D H Gebhard; M B Tompkins; W A Tompkins
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

2.  TaqMan real-time reverse transcription-PCR and JDVp26 antigen capture enzyme-linked immunosorbent assay to quantify Jembrana disease virus load during the acute phase of in vivo infection.

Authors:  Meredith Stewart; Moira Desport; Nining Hartaningsih; Graham Wilcox
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

3.  Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope.

Authors:  J Richardson; A Moraillon; S Baud; A M Cuisinier; P Sonigo; G Pancino
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Unintegrated bovine leukemia virus DNA: association with viral expression and disease.

Authors:  R A Reyes; G L Cockerell
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

5.  Incubation time for feline immunodeficiency virus cultures.

Authors:  S Giannecchini; D Matteucci; P Mazzetti; M Bendinelli
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

6.  Association of plasma viral RNA load with prognosis in cats naturally infected with feline immunodeficiency virus.

Authors:  Yuko Goto; Yoshiaki Nishimura; Kenji Baba; Takuya Mizuno; Yasuyuki Endo; Kenichi Masuda; Koichi Ohno; Hajime Tsujimoto
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Plasma viral RNA load predicts disease progression in accelerated feline immunodeficiency virus infection.

Authors:  L J Diehl; C K Mathiason-Dubard; L L O'Neil; E A Hoover
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

8.  Evidence for CD8+ antiviral activity in cats infected with feline immunodeficiency virus.

Authors:  C R Jeng; R V English; T Childers; M B Tompkins; W A Tompkins
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: implications for vector development.

Authors:  J Johnston; C Power
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

Review 10.  Immunopathogenesis of feline immunodeficiency virus infection in the fetal and neonatal cat.

Authors:  Holly M Kolenda-Roberts; Leah A Kuhnt; Ryan N Jennings; Ayalew Mergia; Nazareth Gengozian; Calvin M Johnson
Journal:  Front Biosci       Date:  2007-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.